CYCLOPHOSPHAMIDE Side Effects

7023668-2 | Chills, Neutropenia, Purulence, Pyrexia
on Sep 29, 2010 Male patient from UNITED STATES , weighting 142.2 lb, was treated with Cyclophosphamide (View Usage). Patient experienced the following unwanted or unexpected effects: chills, neutropenia, purulence, pyrexia. Cyclophosphamide dosage: 1700 Mg. During the same period patient was treated with CYTARABINE (1016 Mg) (View Cytarabine Review and Cytarabine Label ), MERCAPTOPURINE (840 Mg) (View Mercaptopurine Review and Mercaptopurine Label ), METHOTREXATE (45 Mg) (View Methotrexate Review and Methotrexate Label ), PEG L ASPARAGINASE (K H) (4250 Mg) (View Peg-l- Asparaginase (k -h) Review and Peg-l- Asparaginase (k -h) Label ), VINCRISTINE SULFATE (2 Mg) (View Vincristine Sulfate Review and Vincristine Sulfate Label ). Patient was hospitalized.

7022230-5 | Oxygen Saturation Decreased, Respiratory Rate Increased
Patient was taking Cyclophosphamide (View Usage). Patient had the following side effects: oxygen saturation decreased, respiratory rate increased on Sep 20, 2010 from UNITED STATES Additional patient health information: Male patient , 40 years of age, was diagnosed with colon cancer and. Cyclophosphamide dosage: . During the same period patient was treated with FLUDARABINE (View Fludarabine Review and Fludarabine Label ), MFEZ (View Mfez Review and Mfez Label ), ALDESLEUKIN (View Aldesleukin Review and Aldesleukin Label ). Patient was hospitalized.

7019145-5 | Febrile Neutropenia, Myalgia
Adverse event was reported on Sep 22, 2010 by a Female patient taking Cyclophosphamide (View Usage) (Dosage: ) was diagnosed with breast cancer (What is breast cancer?) and. Location: ITALY , 60 years of age, After Cyclophosphamide was administered, patient had the following side effects: febrile neutropenia, myalgia. During the same period patient was treated with DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ). Patient was hospitalized.

7018156-3 | Hypertriglyceridaemia
on Sep 21, 2010 Female patient from AUSTRIA , 54 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Cyclophosphamide (View Usage). Patient experienced the following unwanted or unexpected effects: hypertriglyceridaemia. Cyclophosphamide dosage: . Patient was hospitalized.


7016130-4 | Neutropenia, Urinary Tract Infection
on Sep 17, 2010 Female patient from GREECE , 48 years of age, weighting 163.1 lb, was diagnosed with breast cancer (What is breast cancer?), neutropenia, depression (What is depression?) and was treated with Cyclophosphamide (View Usage). Patient had the following side effects: neutropenia, urinary tract infection (What is urinary tract infection?). Cyclophosphamide dosage: . During the same period patient was treated with METHOTREXATE SODIUM (View Methotrexate Sodium Review and Methotrexate Sodium Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), NEULASTA (View Neulasta Review and Neulasta Label ), ZOFRON (View Zofron Review and Zofron Label ), PRIMPERAN TAB (View Primperan Tab Review and Primperan Tab Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ). Patient was hospitalized.

7016123-7 | Pancreatitis
Patient was taking Cyclophosphamide (View Usage). After Cyclophosphamide was administered, patient had the following side effects: pancreatitis on Sep 16, 2010 from JAPAN Additional patient health information: Male patient , child 7 years of age, was diagnosed with pineal neoplasm and. Cyclophosphamide dosage: . During the same period patient was treated with METHOTREXATE SODIUM (View Methotrexate Sodium Review and Methotrexate Sodium Label ), RANDA (View Randa Review and Randa Label ). Patient was hospitalized.

7015645-2 | Hepatitis B
Adverse event was reported on Sep 24, 2010 by a Male patient taking Cyclophosphamide (View Usage) (Dosage: Dose Was Reduced To 30 Percent) was diagnosed with b-cell lymphoma and. Location: ITALY , 58 years of age, Patient experienced the following unwanted or unexpected effects: hepatitis b (What is hepatitis b?). During the same period patient was treated with DOXORUBICIN HCL (Dose Was Reduced To 30 Percent) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE SULFATE (Dose Was Reduced To 30 Percent) (View Vincristine Sulfate Review and Vincristine Sulfate Label ), RITUXIMAB (Dose Was Reduced To 30 Percent, Re-introduced) (View Rituximab Review and Rituximab Label ), PREDNISONE (Dose Was Reduced To 30 Percent) (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

7014657-2 | Neuropathy Peripheral
on Sep 17, 2010 Female patient from GREECE , 49 years of age, weighting 92.59 lb, was diagnosed with breast cancer (What is breast cancer?), anaemia, depression (What is depression?) and was treated with Cyclophosphamide (View Usage). Patient had the following side effects: neuropathy peripheral. Cyclophosphamide dosage: . During the same period patient was treated with TAXOL (View Taxol Review and Taxol Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), EMEND (View Emend Review and Emend Label ), ZOFRON (View Zofron Review and Zofron Label ), EPOETIN ALFA (View Epoetin Alfa Review and Epoetin Alfa Label ), VENLAFAXINE HYDROCHLORIDE (View Venlafaxine Hydrochloride Review and Venlafaxine Hydrochloride Label ), FENISTIL (View Fenistil Review and Fenistil Label ).

7013868-X | Reversible Posterior Leukoencephalopathy Syndrome
on Sep 13, 2010 Male patient from ITALY , 14 years of age, was diagnosed with stem cell transplant and was treated with Cyclophosphamide (View Usage). After Cyclophosphamide was administered, patient had the following side effects: reversible posterior leukoencephalopathy syndrome. Cyclophosphamide dosage: 10 Mg/kg/day.

7013867-8 | Reversible Posterior Leukoencephalopathy Syndrome
Patient was taking Cyclophosphamide (View Usage). Patient experienced the following unwanted or unexpected effects: reversible posterior leukoencephalopathy syndrome on Sep 13, 2010 from ITALY Additional patient health information: Female patient , child 8 years of age, was diagnosed with stem cell transplant and. Cyclophosphamide dosage: 10 Mg/kg/day.

7013866-6 | Reversible Posterior Leukoencephalopathy Syndrome
Adverse event was reported on Sep 13, 2010 by a Female patient taking Cyclophosphamide (View Usage) (Dosage: 10 Mg/kg/day) was diagnosed with stem cell transplant and. Location: ITALY , child 11 years of age, Patient had the following side effects: reversible posterior leukoencephalopathy syndrome.

7013865-4 | Reversible Posterior Leukoencephalopathy Syndrome
on Sep 13, 2010 Female patient from ITALY , child 9 years of age, was diagnosed with stem cell transplant and was treated with Cyclophosphamide (View Usage). After Cyclophosphamide was administered, patient had the following side effects: reversible posterior leukoencephalopathy syndrome. Cyclophosphamide dosage: 10 Mg/kg/day.

7013864-2 | Reversible Posterior Leukoencephalopathy Syndrome
on Sep 13, 2010 Male patient from ITALY , child 12 years of age, was diagnosed with stem cell transplant and was treated with Cyclophosphamide (View Usage). Patient experienced the following unwanted or unexpected effects: reversible posterior leukoencephalopathy syndrome. Cyclophosphamide dosage: 10 Mg/kg/day.

7013861-7 | Reversible Posterior Leukoencephalopathy Syndrome
Patient was taking Cyclophosphamide (View Usage). Patient had the following side effects: reversible posterior leukoencephalopathy syndrome on Sep 13, 2010 from ITALY Additional patient health information: Male patient , 17 years of age, was diagnosed with stem cell transplant and. Cyclophosphamide dosage: 10 Mg/kg/day.

7013318-3 | Dyspnoea, Leukopenia, Neutropenia, Pain
Adverse event was reported on Sep 17, 2010 by a Female patient taking Cyclophosphamide (View Usage) (Dosage: ) was diagnosed with breast cancer (What is breast cancer?), anaemia, neutropenia and. Location: GREECE , 57 years of age, weighting 172.0 lb, After Cyclophosphamide was administered, patient had the following side effects: dyspnoea, leukopenia, neutropenia, pain (What is pain?). During the same period patient was treated with METHOTREXATE SODIUM (View Methotrexate Sodium Review and Methotrexate Sodium Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), EPOETIN BETA (View Epoetin Beta Review and Epoetin Beta Label ), RESOFERON (View Resoferon Review and Resoferon Label ), ZOFRON (View Zofron Review and Zofron Label ), PRIMPERAN TAB (View Primperan Tab Review and Primperan Tab Label ), NEULASTA (View Neulasta Review and Neulasta Label ). Patient was hospitalized.

7010544-4 | Abdominal Pain, Ascites, Chills, Cough, Dyspepsia, Metastatic Neoplasm, Mucosal Inflammation, Nausea, Neutropenic Infection
on Sep 14, 2010 Female patient from FRANCE , 52 years of age, weighting 121.3 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Cyclophosphamide (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), ascites, chills, cough, dyspepsia, metastatic neoplasm, mucosal inflammation, nausea (What is nausea?), neutropenic infection. Cyclophosphamide dosage: . During the same period patient was treated with TAXOTERE (View Taxotere Review and Taxotere Label ), ADRIAMYCIN PFS (View Adriamycin Pfs Review and Adriamycin Pfs Label ), GEMCITABINE (View Gemcitabine Review and Gemcitabine Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), BENICAR (View Benicar Review and Benicar Label ), SERTRALINE HYDROCHLORIDE (View Sertraline Hydrochloride Review and Sertraline Hydrochloride Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), AMBIEN (View Ambien Review and Ambien Label ). Patient was hospitalized and became disabled.

7010490-6 | Bone Marrow Failure, Diarrhoea, Renal Failure Acute
on Sep 14, 2010 Female patient from FRANCE , 61 years of age, weighting 187.4 lb, was diagnosed with acute myeloid leukaemia, breast cancer (What is breast cancer?) and was treated with Cyclophosphamide (View Usage). Patient had the following side effects: bone marrow failure, diarrhoea, renal failure acute. Cyclophosphamide dosage: . During the same period patient was treated with ETOPOSIDE (View Etoposide Review and Etoposide Label ), CLOFARABINE (View Clofarabine Review and Clofarabine Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), MESNA (View Mesna Review and Mesna Label ), ANASTROZOLE (View Anastrozole Review and Anastrozole Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), STILNOX /FRA/ (View Stilnox /fra/ Review and Stilnox /fra/ Label ), MYOLASTAN (View Myolastan Review and Myolastan Label ). Patient was hospitalized and became disabled.

7010180-X | Hepatic Enzyme Increased
Patient was taking Cyclophosphamide (View Usage). After Cyclophosphamide was administered, patient had the following side effects: hepatic enzyme increased on Sep 13, 2010 from GREECE Additional patient health information: Female patient , 46 years of age, weighting 101.4 lb, was diagnosed with breast cancer (What is breast cancer?), prophylaxis of nausea and vomiting, prophylaxis against gastrointestinal ulcer and. Cyclophosphamide dosage: . During the same period patient was treated with METHOTREXATE SODIUM (View Methotrexate Sodium Review and Methotrexate Sodium Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), GRANISETRON HCL (View Granisetron Hcl Review and Granisetron Hcl Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ).

7010101-X | Congestive Cardiomyopathy
Adverse event was reported on Sep 14, 2010 by a Female patient taking Cyclophosphamide (View Usage) (Dosage: ) was diagnosed with progressive multiple sclerosis and. Location: FRANCE , 34 years of age, Patient experienced the following unwanted or unexpected effects: congestive cardiomyopathy. During the same period patient was treated with BETAFERON (View Betaferon Review and Betaferon Label ).

7010095-7 | Dermatofibrosarcoma
on Sep 14, 2010 Male patient from FRANCE , 34 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Cyclophosphamide (View Usage). Patient had the following side effects: dermatofibrosarcoma. Cyclophosphamide dosage: . During the same period patient was treated with METHOTREXATE SODIUM (View Methotrexate Sodium Review and Methotrexate Sodium Label ), KIDROLASE (View Kidrolase Review and Kidrolase Label ), ONCOVIN (View Oncovin Review and Oncovin Label ), ARACYTINE (View Aracytine Review and Aracytine Label ), DAUNORUBICIN HCL (View Daunorubicin Hcl Review and Daunorubicin Hcl Label ). Patient was hospitalized.

7010034-9 | Venous Thrombosis
on Sep 13, 2010 Female patient from GREECE , 60 years of age, weighting 172.0 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Cyclophosphamide (View Usage). After Cyclophosphamide was administered, patient had the following side effects: venous thrombosis. Cyclophosphamide dosage: . During the same period patient was treated with METHOTREXATE SODIUM (View Methotrexate Sodium Review and Methotrexate Sodium Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ).

7009243-4 | Cerebral Toxoplasmosis, Progressive Multifocal Leukoencephalopathy
Patient was taking Cyclophosphamide (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral toxoplasmosis, progressive multifocal leukoencephalopathy on Sep 20, 2010 from Additional patient health information: Male patient , 63 years of age, was diagnosed with chronic lymphocytic leukaemia and. Cyclophosphamide dosage: . During the same period patient was treated with FLUDARABINE (View Fludarabine Review and Fludarabine Label ), RITUXIMAB (View Rituximab Review and Rituximab Label ). Patient was hospitalized.

7008016-6 | Anxiety, Back Pain, Face Oedema, Fluid Retention, Laryngotracheal Oedema, Vomiting
Adverse event was reported on Sep 13, 2010 by a Female patient taking Cyclophosphamide (View Usage) (Dosage: ) was diagnosed with lymphocytic leukaemia and. Location: POLAND , child 3 years of age, weighting 33.07 lb, Patient had the following side effects: anxiety (What is anxiety?), back pain (What is back pain?), face oedema, fluid retention, laryngotracheal oedema, vomiting. During the same period patient was treated with MESNA (View Mesna Review and Mesna Label ), MERCAPTOPURINE (View Mercaptopurine Review and Mercaptopurine Label ), ZOFRAN (View Zofran Review and Zofran Label ). Patient was hospitalized.

7005426-8 | Cardiac Arrest, Multi-organ Failure, Neutropenia, Nosocomial Infection, Respiratory Failure, Strongyloidiasis
on Sep 15, 2010 Male patient from , 49 years of age, was diagnosed with vasculitis (What is vasculitis?), nosocomial infection, evidence based treatment, diabetes mellitus and was treated with Cyclophosphamide (View Usage). After Cyclophosphamide was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), multi-organ failure, neutropenia, nosocomial infection, respiratory failure, strongyloidiasis. Cyclophosphamide dosage: . During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), CEFTAZIDIME (View Ceftazidime Review and Ceftazidime Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), ANTIDIABETIC (View Antidiabetic Review and Antidiabetic Label ). Patient was hospitalized.

7005027-1 | Karyotype Analysis Abnormal, Myelodysplastic Syndrome
on Sep 14, 2010 Male patient from FRANCE , 72 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Cyclophosphamide (View Usage). Patient experienced the following unwanted or unexpected effects: karyotype analysis abnormal, myelodysplastic syndrome. Cyclophosphamide dosage: . During the same period patient was treated with MABTHERA (View Mabthera Review and Mabthera Label ), FLUDARA (View Fludara Review and Fludara Label ). Patient was hospitalized.

7004990-2 | Hepatic Enzyme Increased
Patient was taking Cyclophosphamide (View Usage). Patient had the following side effects: hepatic enzyme increased on Sep 13, 2010 from GREECE Additional patient health information: Female patient , 56 years of age, weighting 165.3 lb, was diagnosed with breast cancer (What is breast cancer?), nausea (What is nausea?), abdominal discomfort, hypertension and. Cyclophosphamide dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), GRANISETRON HCL (View Granisetron Hcl Review and Granisetron Hcl Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), TENORETIC 100 (View Tenoretic 100 Review and Tenoretic 100 Label ).

7004959-8 | Cerebellar Syndrome, Gait Disturbance, Nervous System Disorder
Adverse event was reported on Sep 10, 2010 by a Female patient taking Cyclophosphamide (View Usage) (Dosage: ) was diagnosed with acute myeloid leukaemia and. Location: FRANCE , 39 years of age, After Cyclophosphamide was administered, patient had the following side effects: cerebellar syndrome, gait disturbance, nervous system disorder. During the same period patient was treated with IDARUBICIN HCL (View Idarubicin Hcl Review and Idarubicin Hcl Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), BUSULFAN (View Busulfan Review and Busulfan Label ).

7003715-4 | Congestive Cardiomyopathy, Neutropenia, Pneumonia, Septic Shock
on Sep 09, 2010 Male patient from CZECH REPUBLIC , 44 years of age, was diagnosed with diffuse large b-cell lymphoma, prophylaxis and was treated with Cyclophosphamide (View Usage). Patient experienced the following unwanted or unexpected effects: congestive cardiomyopathy, neutropenia, pneumonia (What is pneumonia?), septic shock. Cyclophosphamide dosage: . During the same period patient was treated with DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE SULFATE (Day 1) (View Vincristine Sulfate Review and Vincristine Sulfate Label ), RITUXIMAB (View Rituximab Review and Rituximab Label ), PREDNISONE (Days 1-5) (View Prednisone Review and Prednisone Label ), METHYLPREDNISOLONE (Days 1-5) (View Methylprednisolone Review and Methylprednisolone Label ), GRANULOCYTE CSF (View Granulocyte Csf Review and Granulocyte Csf Label ). Patient was hospitalized.

7002901-7 | Renal Failure Acute
on Sep 14, 2010 Male patient from JAPAN , 30 years of age, was diagnosed with rhabdoid tumour of the kidney and was treated with Cyclophosphamide (View Usage). Patient had the following side effects: renal failure acute. Cyclophosphamide dosage: . During the same period patient was treated with IFOSFAMIDE (View Ifosfamide Review and Ifosfamide Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), VINCRISTINE SULFATE (View Vincristine Sulfate Review and Vincristine Sulfate Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ).

7002895-4 | Abdominal Pain Upper, Anxiety, Chills, Dysphagia, Dyspnoea, Face Oedema, Headache, Oedema Peripheral, Oxygen Saturation Decreased
Patient was taking Cyclophosphamide (View Usage). After Cyclophosphamide was administered, patient had the following side effects: abdominal pain upper, anxiety (What is anxiety?), chills, dysphagia, dyspnoea, face oedema, headache (What is headache?), oedema peripheral, oxygen saturation decreased on Sep 09, 2010 from POLAND Additional patient health information: Male patient , child 11 years of age, weighting 110.2 lb, was diagnosed with acute lymphocytic leukaemia and. Cyclophosphamide dosage: . During the same period patient was treated with MESNA (View Mesna Review and Mesna Label ), ZOFRAN (View Zofran Review and Zofran Label ), SYLIMAROL (View Sylimarol Review and Sylimarol Label ), HEPATIL (View Hepatil Review and Hepatil Label ), MERCAPTOPURINE (View Mercaptopurine Review and Mercaptopurine Label ). Patient was hospitalized.

7002779-1 | Asthenia, Cardiac Arrest, Dyspnoea, Haemoptysis, Hypotension, Pyrexia, Strongyloidiasis
Adverse event was reported on Sep 11, 2010 by a Male patient taking Cyclophosphamide (View Usage) (Dosage: ) was diagnosed with vasculitis (What is vasculitis?) and. Location: GREECE , 49 years of age, Patient experienced the following unwanted or unexpected effects: asthenia, cardiac arrest (What is cardiac arrest?), dyspnoea, haemoptysis, hypotension, pyrexia, strongyloidiasis. During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ).

6993025-3 | Palmar-plantar Erythrodysaesthesia Syndrome
on Sep 13, 2010 Female patient from , 63 years of age, was diagnosed with breast cancer stage iii, prophylaxis of nausea and vomiting and was treated with Cyclophosphamide (View Usage). Patient had the following side effects: palmar-plantar erythrodysaesthesia syndrome. Cyclophosphamide dosage: . During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), GRANISETRON HCL (View Granisetron Hcl Review and Granisetron Hcl Label ), 5 FLUORURACIL (View 5-fluoruracil Review and 5-fluoruracil Label ), EPIRUBICIN (View Epirubicin Review and Epirubicin Label ). Patient was hospitalized.

6987611-4 | Aspergillosis, Congestive Cardiomyopathy, Neutropenia, Pneumonia, Pseudomonas Infection, Septic Shock
on Sep 14, 2010 Male patient from , 44 years of age, was diagnosed with diffuse large b-cell lymphoma stage iii, prophylaxis, pneumonia (What is pneumonia?) and was treated with Cyclophosphamide (View Usage). After Cyclophosphamide was administered, patient had the following side effects: aspergillosis, congestive cardiomyopathy, neutropenia, pneumonia (What is pneumonia?), pseudomonas infection, septic shock. Cyclophosphamide dosage: . During the same period patient was treated with PREDNISONE (100 Mg) (View Prednisone Review and Prednisone Label ), RITUXIMAB (View Rituximab Review and Rituximab Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), GRANULOCYTE COLONY STIMULATING FACTOR (View Granulocyte Colony-stimulating Factor Review and Granulocyte Colony-stimulating Factor Label ), PIPERACILLIN AND TAZOBACTAM (View Piperacillin And Tazobactam Review and Piperacillin And Tazobactam Label ). Patient was hospitalized.

6987302-X | Dyspnoea, Leukopenia, Neutropenia, Pain
Patient was taking Cyclophosphamide (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, leukopenia, neutropenia, pain (What is pain?) on Sep 07, 2010 from GREECE Additional patient health information: Female patient , 57 years of age, weighting 172.0 lb, was diagnosed with breast cancer (What is breast cancer?), anaemia, neutropenia and. Cyclophosphamide dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), EPOETIN BETA (View Epoetin Beta Review and Epoetin Beta Label ), RESOFERON (View Resoferon Review and Resoferon Label ), ZOFRON (View Zofron Review and Zofron Label ), PRIMPERAN TAB (View Primperan Tab Review and Primperan Tab Label ), NEULASTA (View Neulasta Review and Neulasta Label ). Patient was hospitalized.

6985947-4 | Cerebral Venous Thrombosis
Adverse event was reported on Sep 08, 2010 by a Male patient taking Cyclophosphamide (View Usage) (Dosage: ) was diagnosed with precursor t-lymphoblastic lymphoma/leukaemia and. Location: FRANCE , 40 years of age, Patient had the following side effects: cerebral venous thrombosis. During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), KIDROLASE (View Kidrolase Review and Kidrolase Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ), VINCRISTINE SULFATE (View Vincristine Sulfate Review and Vincristine Sulfate Label ).

6985901-2 | Neuropathy Peripheral
on Sep 07, 2010 Female patient from GREECE , 49 years of age, weighting 92.59 lb, was diagnosed with breast cancer (What is breast cancer?), anaemia, depression (What is depression?) and was treated with Cyclophosphamide (View Usage). After Cyclophosphamide was administered, patient had the following side effects: neuropathy peripheral. Cyclophosphamide dosage: . During the same period patient was treated with TAXOL (View Taxol Review and Taxol Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), EMEND (View Emend Review and Emend Label ), ZOFRON (View Zofron Review and Zofron Label ), EPOETIN ALFA (View Epoetin Alfa Review and Epoetin Alfa Label ), VENLAFAXINE HYDROCHLORIDE (View Venlafaxine Hydrochloride Review and Venlafaxine Hydrochloride Label ), FENISTIL (View Fenistil Review and Fenistil Label ).

6984855-2 | Device Related Infection, Muscle Contractions Involuntary, Pneumocystis Jiroveci Pneumonia, Tic
on Sep 10, 2010 Male patient from UNITED KINGDOM , 13 years of age, was diagnosed with epstein-barr virus associated lymphoproliferative disorder and was treated with Cyclophosphamide (View Usage). Patient experienced the following unwanted or unexpected effects: device related infection, muscle contractions involuntary, pneumocystis jiroveci pneumonia, tic (What is tic?). Cyclophosphamide dosage: . During the same period patient was treated with ETOPOSIDE (View Etoposide Review and Etoposide Label ), VINCRISTINE SULFATE (View Vincristine Sulfate Review and Vincristine Sulfate Label ), CAELYX (View Caelyx Review and Caelyx Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), METHOTREXATE (Took 5 Doses) (View Methotrexate Review and Methotrexate Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), RITUXIMAB (View Rituximab Review and Rituximab Label ), THIOGUANINE (View Thioguanine Review and Thioguanine Label ). Patient was hospitalized.

6979220-8 | Leukaemia Recurrent, Polyuria, Renal Failure Acute, Tumour Lysis Syndrome, Uraemic Encephalopathy
Patient was taking Cyclophosphamide (View Usage). Patient had the following side effects: leukaemia recurrent, polyuria, renal failure acute, tumour lysis syndrome, uraemic encephalopathy on Sep 08, 2010 from Additional patient health information: Male patient , 19 years of age, was diagnosed with t-cell type acute leukaemia and. Cyclophosphamide dosage: 1 G. During the same period patient was treated with PREDNISOLONE (64 Mg) (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

6978287-0 | Neutropenia, Urinary Tract Infection
Adverse event was reported on Sep 07, 2010 by a Female patient taking Cyclophosphamide (View Usage) (Dosage: ) was diagnosed with breast cancer (What is breast cancer?), neutropenia, depression (What is depression?) and. Location: GREECE , 48 years of age, weighting 163.1 lb, After Cyclophosphamide was administered, patient had the following side effects: neutropenia, urinary tract infection (What is urinary tract infection?). During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), NEULASTA (View Neulasta Review and Neulasta Label ), ZOFRON (View Zofron Review and Zofron Label ), PRIMPERAN TAB (View Primperan Tab Review and Primperan Tab Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ). Patient was hospitalized.

6978284-5 | Acute Pulmonary Oedema, Left Ventricular Failure
on Sep 06, 2010 Female patient from FRANCE , 57 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Cyclophosphamide (View Usage). Patient experienced the following unwanted or unexpected effects: acute pulmonary oedema, left ventricular failure. Cyclophosphamide dosage: . During the same period patient was treated with EPIRUBICIN HYDROCHLORIDE (View Epirubicin Hydrochloride Review and Epirubicin Hydrochloride Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), TAXOTERE (View Taxotere Review and Taxotere Label ), ANASTROZOLE (View Anastrozole Review and Anastrozole Label ), LOXAPAC (View Loxapac Review and Loxapac Label ), LEXOMIL (View Lexomil Review and Lexomil Label ). Patient was hospitalized.

6977354-5 | Respiratory Tract Infection
on Sep 03, 2010 Male patient from GERMANY , 78 years of age, was diagnosed with temporal arteritis, gastritis, diabetic neuropathy, glaucoma (What is glaucoma?), atrial fibrillation (What is atrial fibrillation?), goitre and was treated with Cyclophosphamide (View Usage). Patient had the following side effects: respiratory tract infection. Cyclophosphamide dosage: . During the same period patient was treated with PREDNISOLON (View Prednisolon Review and Prednisolon Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), PREGABALIN (View Pregabalin Review and Pregabalin Label ), XALATAN (View Xalatan Review and Xalatan Label ), TIM OPHTAL (View Tim-ophtal Review and Tim-ophtal Label ), FALITHROM ^HEXAL^ (View Falithrom ^hexal^ Review and Falithrom ^hexal^ Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized.

6977144-3 | Reversible Posterior Leukoencephalopathy Syndrome
Patient was taking Cyclophosphamide (View Usage). After Cyclophosphamide was administered, patient had the following side effects: reversible posterior leukoencephalopathy syndrome on Aug 30, 2010 from JAPAN Additional patient health information: Female patient , 54 years of age, was diagnosed with immunosuppression and. Cyclophosphamide dosage: Unk.

6975909-5 | Renal Failure
Adverse event was reported on Sep 02, 2010 by a Male patient taking Cyclophosphamide (View Usage) (Dosage: ) was diagnosed with non-hodgkin's lymphoma, antibiotic prophylaxis and. Location: ITALY , 17 years of age, Patient experienced the following unwanted or unexpected effects: renal failure. During the same period patient was treated with CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), AMIKACIN (View Amikacin Review and Amikacin Label ), CEFTAZIDIME (View Ceftazidime Review and Ceftazidime Label ), ZOVIRAX (View Zovirax Review and Zovirax Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), RANIDIL (View Ranidil Review and Ranidil Label ), DEURSIL (View Deursil Review and Deursil Label ), LASIX (View Lasix Review and Lasix Label ).

6974032-3 | Dementia
on Sep 02, 2010 Female patient from FRANCE , 90 years of age, weighting 108.0 lb, was treated with Cyclophosphamide (View Usage). Patient had the following side effects: dementia (What is dementia?). Cyclophosphamide dosage: . During the same period patient was treated with METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ). Patient was hospitalized and became disabled.

6974026-8 | Tremor
on Sep 02, 2010 Female patient from GERMANY , 66 years of age, weighting 143.3 lb, was diagnosed with breast cancer (What is breast cancer?), hypertension, cystitis and was treated with Cyclophosphamide (View Usage). After Cyclophosphamide was administered, patient had the following side effects: tremor. Cyclophosphamide dosage: . During the same period patient was treated with TAXOTERE (View Taxotere Review and Taxotere Label ), BISOHEXAL (View Bisohexal Review and Bisohexal Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), UROMITEXAN (View Uromitexan Review and Uromitexan Label ).

6974022-0 | Febrile Neutropenia, Hyperpyrexia, Intestinal Obstruction, Urinary Tract Infection
Patient was taking Cyclophosphamide (View Usage). Patient experienced the following unwanted or unexpected effects: febrile neutropenia, hyperpyrexia, intestinal obstruction, urinary tract infection (What is urinary tract infection?) on Sep 02, 2010 from ITALY Additional patient health information: Female patient , 70 years of age, was diagnosed with non-hodgkin's lymphoma and. Cyclophosphamide dosage: . During the same period patient was treated with MABTHERA (View Mabthera Review and Mabthera Label ), VINCRISTINE SULFATE (View Vincristine Sulfate Review and Vincristine Sulfate Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), TRIMETON (View Trimeton Review and Trimeton Label ). Patient was hospitalized.

6973069-8 | Febrile Neutropenia, Haematochezia, Hepatic Function Abnormal, Hypovolaemic Shock, Impaired Gastric Emptying
Adverse event was reported on Sep 02, 2010 by a Male patient taking Cyclophosphamide (View Usage) (Dosage: ) was diagnosed with lymphoma (What is lymphoma?) and. Location: JAPAN , 85 years of age, Patient had the following side effects: febrile neutropenia, haematochezia, hepatic function abnormal, hypovolaemic shock, impaired gastric emptying. During the same period patient was treated with DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE SULFATE (Infusion) (View Vincristine Sulfate Review and Vincristine Sulfate Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

6971898-8 | Dyspnoea, Electromechanical Dissociation, No Therapeutic Response, Oxygen Saturation Decreased, Respiratory Disorder, Tachypnoea
on Sep 08, 2010 Female patient from UNITED STATES , weighting 200.0 lb, was treated with Cyclophosphamide (View Usage). After Cyclophosphamide was administered, patient had the following side effects: dyspnoea, electromechanical dissociation, no therapeutic response, oxygen saturation decreased, respiratory disorder, tachypnoea. Cyclophosphamide dosage: 1200 Mg. During the same period patient was treated with PENTOSTATIN (8 Mg) (View Pentostatin Review and Pentostatin Label ), RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) (750 Mg) (View Rituximab (moab C2b8 Anti Cd20, Chimeric) Review and Rituximab (moab C2b8 Anti Cd20, Chimeric) Label ). Patient was hospitalized.

6971384-5 | Asthenia, Condition Aggravated, Multiple Myeloma, Neuralgia
on Sep 01, 2010 Female patient from , 61 years of age, was diagnosed with pemphigus (What is pemphigus?), multiple myeloma (What is multiple myeloma?) and was treated with Cyclophosphamide (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, condition aggravated, multiple myeloma (What is multiple myeloma?), neuralgia. Cyclophosphamide dosage: 50 Mg. During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), RITUXIMAB (View Rituximab Review and Rituximab Label ). Patient was hospitalized.

6970039-0 | Febrile Bone Marrow Aplasia, Septic Shock
Patient was taking Cyclophosphamide (View Usage). Patient had the following side effects: febrile bone marrow aplasia, septic shock on Sep 01, 2010 from FRANCE Additional patient health information: Female patient , 64 years of age, . Cyclophosphamide dosage: . During the same period patient was treated with TAXOTERE (View Taxotere Review and Taxotere Label ), MEDROL (View Medrol Review and Medrol Label ).